{"id":53494,"date":"2023-09-20T09:47:06","date_gmt":"2023-09-20T09:47:06","guid":{"rendered":"https:\/\/medsname.com\/siromus\/"},"modified":"2026-04-30T10:25:11","modified_gmt":"2026-04-30T10:25:11","slug":"siromus","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/siromus\/","title":{"rendered":"Siromus"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Siromus?<\/h3>\n<p style=\"margin:0;\"><strong>Siromus<\/strong> je peror\u00e1ln\u00ed tableta od Sun Pharma obsahuj\u00edc\u00ed <strong>sirolimus 1 mg<\/strong> \u2014 jeden <strong>inhibitor mTOR (mammalian target of rapamycin)<\/strong> p\u016fvodn\u011b izolovan\u00fd z <em>Streptomyces hygroscopicus<\/em> na Velikono\u010dn\u00edm ostrov\u011b (rapa nui \u2014 odtud rapamycin). Prvn\u00ed linie udr\u017eovac\u00ed imunosupresivn\u00ed terapie u <strong>transplantace ledvin<\/strong> (s n\u00edzkou d\u00e1vkou inhibitoru kalcineurinu nebo jako re\u017eim bez kalcineurinu). Tak\u00e9 schv\u00e1leno FDA pro <strong>lymfangioleiomyomat\u00f3za (LAM)<\/strong>, a pou\u017e\u00edv\u00e1no off-label u <strong>tuber\u00f3zn\u00ed skler\u00f3za (TSC)<\/strong>- souvisej\u00edc\u00ed stavy v\u010detn\u011b subependym\u00e1ln\u00edho obrovskobun\u011b\u010dn\u00e9ho astrocytomu (SEGA), ren\u00e1ln\u00edho angiomyolipomu a ko\u017en\u00edch projev\u016f. Standardn\u00ed udr\u017eovac\u00ed l\u00e9\u010dba po transplantaci: <strong>2\u20135 mg jednou denn\u011b<\/strong> s terapeutick\u00fdm monitorov\u00e1n\u00edm l\u00e9\u010diva (c\u00edlov\u00e9 hladiny 4\u201312 ng\/mL v z\u00e1vislosti na re\u017eimu). <strong>FDA \u010dern\u00e1 sk\u0159\u00ed\u0148ka: zv\u00fd\u0161en\u00e1 mortalita a tromb\u00f3za jatern\u00ed tepny u transplantace jater; dehiscence bronchi\u00e1ln\u00ed anastom\u00f3zy u transplantace plic.<\/strong> Povinn\u00e9: lipidov\u00fd panel, FBC, ren\u00e1ln\u00ed funkce, monitorov\u00e1n\u00ed glyk\u00e9mie nala\u010dno; surveillance pneumonitidy. Celo\u017eivotn\u00ed ochrana p\u0159ed sluncem (sign\u00e1l ko\u017en\u00edho karcinomu).<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\u26a0 Vy\u017eaduje se odborn\u00fd dohled.<\/strong> Imunosupresiva po transplantaci mus\u00ed b\u00fdt p\u0159edepisov\u00e1na a monitorov\u00e1na transplantologem nebo revmatologem. Terapeutick\u00fd monitoring l\u00e9k\u016f, screening infekc\u00ed a prevence t\u011bhotenstv\u00ed jsou povinn\u00e9 sou\u010d\u00e1sti bezpe\u010dn\u00e9ho u\u017e\u00edv\u00e1n\u00ed. Nikdy neza\u010d\u00ednejte, nep\u0159eru\u0161ujte ani nem\u011b\u0148te d\u00e1vkov\u00e1n\u00ed bez odborn\u00e9ho dohledu.<\/div>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 \u0160ifrovan\u00e9 platby<\/strong> \u00b7 <strong>\ud83d\udcb3 Ov\u011b\u0159en\u00fd platebn\u00ed procesor<\/strong> \u00b7 <strong>\ud83d\ude9a Doprava do cel\u00e9ho sv\u011bta<\/strong> \u00b7 <strong>\u2b50 4,9\/5 od 1 400+ z\u00e1kazn\u00edk\u016f<\/strong>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;\"><strong>\u26a0 D\u016fle\u017eit\u00e9 \u2013 tento l\u00e9k nen\u00ed prim\u00e1rn\u011b ur\u010den pro onkologii.<\/strong> Siromus je aktu\u00e1ln\u011b za\u0159azen v kategorii Protin\u00e1dorov\u00e9 l\u00e9ky, ale prim\u00e1rn\u011b se jedn\u00e1 o <strong>imunosupresivum po transplantaci<\/strong>. mTOR dr\u00e1ha je zapojena do mnoha typ\u016f rakoviny a existuje ur\u010dit\u00fd onkologick\u00fd v\u00fdzkum, ale standardn\u00ed protin\u00e1dorov\u00e1 l\u00e9\u010dba vyu\u017e\u00edv\u00e1 p\u0159\u00edbuznou l\u00e1tku <strong>everolimus<\/strong> (nikoli sirolimus). Pro skute\u010dnou l\u00e9\u010dbu rakoviny nav\u0161tivte na\u0161e <a href=\"\/cs\/anti-cancer-medication\/\">Protin\u00e1dorov\u00e9 l\u00e9ky<\/a> kategorie pro inhibitory kin\u00e1z, hormon\u00e1ln\u00ed terapie, alkyla\u010dn\u00ed \u010dinidla, antimetabolity a imunoterapii.<\/div>\n<h2 class=\"wp-block-heading\">Co je Siromus?<\/h2>\n<p>Siromus je peror\u00e1ln\u00ed tableta od Sun Pharma obsahuj\u00edc\u00ed <strong>sirolimus 1 mg<\/strong>. Sirolimus (tak\u00e9 zn\u00e1m\u00fd jako rapamycin) je makrolidov\u00e1 slou\u010denina, kter\u00e1 se v\u00e1\u017ee na intracelul\u00e1rn\u00ed protein FKBP12 za vzniku komplexu, kter\u00fd inhibuje <strong>mTOR (mammalian target of rapamycin)<\/strong> serin-threonin kin\u00e1zu. mTOR je hlavn\u00ed regul\u00e1tor r\u016fstu, proliferace a p\u0159e\u017eit\u00ed bun\u011bk v r\u00e1mci signalizace r\u016fstov\u00fdmi faktory a \u017eivinami. Sirolimus byl p\u016fvodn\u011b vyvinut spole\u010dnost\u00ed Wyeth a schv\u00e1len FDA v roce 1999 (obchodn\u00ed n\u00e1zev Rapamune). Je mate\u0159skou slou\u010deninou strukturn\u011b podobn\u00fdch everolimu a temsirolimu.<\/p>\n<h2 class=\"wp-block-heading\">Jak Siromus funguje?<\/h2>\n<ul>\n<li><strong>Sirolimus se v\u00e1\u017ee na FKBP12<\/strong> \u2014 stejn\u00fd intracelul\u00e1rn\u00ed receptor jako takrolimus (FK506). Nicm\u00e9n\u011b komplex sirolimus-FKBP12 inhibuje jin\u00fd c\u00edlov\u00fd protein (mTOR) ne\u017e takrolimus-FKBP12, kter\u00fd inhibuje kalcineurin.<\/li>\n<li><strong>Inhibice mTOR<\/strong> blokuje IL-2 \u0159\u00edzen\u00fd p\u0159echod z G1 do S f\u00e1ze lymfocyt\u00e1rn\u00edho bun\u011b\u010dn\u00e9ho cyklu \u2014 potla\u010duje proliferaci T-bun\u011bk a B-bun\u011bk bez jejich deplece.<\/li>\n<li><strong>Antifibrotick\u00e9 a antiangiogenn\u00ed \u00fa\u010dinky<\/strong> \u2014 inhibice mTOR sni\u017euje VEGF signalizaci a vysv\u011btluje \u00fa\u010dinnost u LAM a TSC souvisej\u00edc\u00edch l\u00e9z\u00ed.<\/li>\n<li><strong>Odli\u0161n\u00fd mechanismus od inhibitor\u016f kalcineurinu<\/strong> \u2014 umo\u017e\u0148uje minimalizaci nebo eliminaci inhibitor\u016f kalcineurinu v n\u011bkter\u00fdch transplanta\u010dn\u00edch protokolech, \u010d\u00edm\u017e sni\u017euje nefrotoxicitu v pozdn\u00ed f\u00e1zi udr\u017eovac\u00ed l\u00e9\u010dby po transplantaci.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Pou\u017eit\u00ed a indikace<\/h2>\n<ul>\n<li><strong>\u00dadr\u017eba po transplantaci ledvin<\/strong> \u2014 od 2\u20134 m\u011bs\u00edc\u016f po transplantaci d\u00e1le, s minimalizac\u00ed kalcineurinov\u00fdch inhibitor\u016f nebo v re\u017eimech bez kalcineurinov\u00fdch inhibitor\u016f. Zvl\u00e1\u0161t\u011b u\u017eite\u010dn\u00e9 u pacient\u016f s nefrotoxicitou kalcineurinov\u00fdch inhibitor\u016f.<\/li>\n<li><strong>Lymfangioleiomyomat\u00f3za (LAM)<\/strong> \u2014 schv\u00e1leno FDA 2015 (studie MILES) \u2014 stabilizuje plicn\u00ed funkci u t\u00e9to vz\u00e1cn\u00e9 progresivn\u00ed cystick\u00e9 plicn\u00ed choroby postihuj\u00edc\u00ed t\u00e9m\u011b\u0159 v\u00fdhradn\u011b \u017eeny.<\/li>\n<li><strong>L\u00e9ze spojen\u00e9 s tuber\u00f3zn\u00ed skler\u00f3zou (TSC)<\/strong> (mimo schv\u00e1len\u00e9 indikace v n\u011bkter\u00fdch jurisdikc\u00edch; everolimus je schv\u00e1len\u00fd p\u0159\u00edpravek): subependym\u00e1ln\u00ed obrovskobun\u011b\u010dn\u00fd astrocytom (SEGA), ren\u00e1ln\u00ed angiomyolipom, obli\u010dejov\u00e9 angiofibromy (lok\u00e1ln\u00ed), refraktern\u00ed epilepsie.<\/li>\n<li><strong>Plicn\u00ed arteri\u00e1ln\u00ed hypertenze (mimo schv\u00e1len\u00e9 indikace):<\/strong> n\u011bkter\u00e9 specializovan\u00e9 pou\u017eit\u00ed.<\/li>\n<li><strong>L\u00e9kov\u011b eluuj\u00edc\u00ed koron\u00e1rn\u00ed stenty:<\/strong> sirolimus a analogy pokr\u00fdvaj\u00ed bal\u00f3nkov\u011b expandovateln\u00e9 stenty k prevenci resten\u00f3zy (samostatn\u00e1 indikace pro zdravotnick\u00e9 prost\u0159edky).<\/li>\n<\/ul>\n<p>Siromus je <strong>ne<\/strong> indikov\u00e1n k prim\u00e1rn\u00ed l\u00e9\u010db\u011b rakoviny. Bl\u00edzce p\u0159\u00edbuzn\u00fd everolimus m\u00e1 v\u00edce onkologick\u00fdch indikac\u00ed (HR+ HER2- karcinom prsu s exemestanem, pokro\u010dil\u00fd ren\u00e1ln\u00ed bun\u011b\u010dn\u00fd karcinom, neuroendokrinn\u00ed tumory, SEGA, TSC angiomyolipom), ale sirolimus samotn\u00fd je prim\u00e1rn\u011b zam\u011b\u0159en na transplantace.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed Siromusu a jak ho u\u017e\u00edvat<\/h2>\n<p>Standardn\u00ed udr\u017eovac\u00ed d\u00e1vka: <strong>2\u20135 mg jednou denn\u011b<\/strong> po nasycovac\u00ed d\u00e1vce. Terapeutick\u00e9 monitorov\u00e1n\u00ed hladin l\u00e9ku je povinn\u00e9 \u2014 c\u00edlov\u00e9 koncentrace v krvi z\u00e1vis\u00ed na indikaci a kombinovan\u00e9m re\u017eimu.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;\">Indikace<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">D\u00e1vkovac\u00ed re\u017eim<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">C\u00edlov\u00e9 plazmatick\u00e9 minimum (ng\/mL)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ren\u00e1ln\u00ed transplantace + cyklosporin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">6 mg \u00favodn\u00ed d\u00e1vka, pot\u00e9 2 mg\/den<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">4\u201312<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ren\u00e1ln\u00ed transplantace bez kalcineurinov\u00fdch inhibitor\u016f<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">15 mg \u00favodn\u00ed d\u00e1vka, pot\u00e9 5 mg\/den<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">12\u201320 prvn\u00ed rok<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">LAM<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">2 mg\/den, titrovat podle plazmatick\u00e9ho minima<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">5\u201315<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">TSC angiomyolipom \/ SEGA<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Specializovan\u00e1 titrace<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">5\u201315 (preferovan\u00fd everolimus)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 class=\"wp-block-heading\">Jak spr\u00e1vn\u011b u\u017e\u00edvat Siromus<\/h3>\n<ol>\n<li><strong>Jednou denn\u011b ve stejnou dobu ka\u017ed\u00fd den.<\/strong> D\u016fslednost je d\u016fle\u017eit\u011bj\u0161\u00ed ne\u017e r\u00e1no versus ve\u010der.<\/li>\n<li><strong>U\u017e\u00edvejte pravideln\u011b s j\u00eddlem nebo bez j\u00eddla.<\/strong> Vysokotu\u010dn\u00e1 strava zvy\u0161uje AUC o ~35 % a Cmax o ~65 % \u2014 vyberte si jednu variantu a t\u00e9 se dr\u017ete; nep\u0159ech\u00e1zejte mezi u\u017eit\u00edm nala\u010dno a po j\u00eddle, proto\u017ee to m\u011bn\u00ed hladiny v trough.<\/li>\n<li><strong>Tablety polykejte vcelku se sklenic\u00ed vody.<\/strong> Nedr\u0165te, ne\u017ev\u00fdkejte ani ned\u011blte.<\/li>\n<li><strong>Povinn\u00e9 monitorov\u00e1n\u00ed:<\/strong> hladina sirolimu v pln\u00e9 krvi (odb\u011br 24 hodin po d\u00e1vce, t\u011bsn\u011b p\u0159ed dal\u0161\u00ed d\u00e1vkou). Po\u010d\u00e1te\u010dn\u00ed kontrola po 1 t\u00fddnu, pot\u00e9 t\u00fddn\u011b do stabilizace, n\u00e1sledn\u011b ka\u017ed\u00e9 3\u20136 m\u011bs\u00edc\u016f. Lipidov\u00fd panel na za\u010d\u00e1tku + m\u011bs\u00ed\u010dn\u011b zpo\u010d\u00e1tku. Krevn\u00ed obraz, jatern\u00ed testy, funkce ledvin, glyk\u00e9mie nala\u010dno m\u011bs\u00ed\u010dn\u011b zpo\u010d\u00e1tku.<\/li>\n<li><strong>Ochrana poko\u017eky:<\/strong> Denn\u011b pou\u017e\u00edvejte opalovac\u00ed kr\u00e9m s SPF 50+, \u0161irok\u00fd klobouk, dlouh\u00e9 ruk\u00e1vy. Ro\u010dn\u00ed dermatologick\u00e9 vy\u0161et\u0159en\u00ed cel\u00e9ho t\u011bla \u2014 dlouhodob\u00e1 inhibice mTOR zvy\u0161uje riziko ko\u017en\u00edch n\u00e1dor\u016f.<\/li>\n<li><strong>O\u010dkov\u00e1n\u00ed:<\/strong> \u017eiv\u00e9 vakc\u00edny (MMR, plan\u00e9 ne\u0161tovice, \u017elut\u00e1 zimnice, BCG) jsou <strong>kontraindikov\u00e1no<\/strong>. Doporu\u010duj\u00ed se inaktivovan\u00e9 vakc\u00edny (ro\u010dn\u00ed ch\u0159ipka, COVID, pneumokokov\u00e9).<\/li>\n<li><strong>P\u00e9\u010de o r\u00e1ny:<\/strong> sirolimus naru\u0161uje hojen\u00ed ran. Do\u010dasn\u011b vysa\u010fte p\u0159ed pl\u00e1novanou operac\u00ed (obvykle 2\u20134 t\u00fddny p\u0159ed v\u00fdkonem) a obnovte a\u017e po \u00fapln\u00e9m zhojen\u00ed r\u00e1ny.<\/li>\n<li><strong>Nevysazujte bez pokyn\u016f specialisty.<\/strong><\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky Siromusu<\/h2>\n<p><strong>\u010cast\u00e9 (\u010dasto z\u00e1visl\u00e9 na d\u00e1vce):<\/strong><\/p>\n<ul>\n<li>Hyperlipid\u00e9mie (vzestup cholesterolu a triglycerid\u016f) \u2014 dominantn\u00ed metabolick\u00fd vedlej\u0161\u00ed \u00fa\u010dinek; l\u00e9\u010dit statiny<\/li>\n<li>Aft\u00f3zn\u00ed (\u00fastn\u00ed) v\u0159edy \/ mukozitida \u2014 zejm\u00e9na na za\u010d\u00e1tku l\u00e9\u010dby<\/li>\n<li>Akn\u00e9 a ko\u017en\u00ed vyr\u00e1\u017eka<\/li>\n<li>Perifern\u00ed ed\u00e9m<\/li>\n<li>Hypertenze<\/li>\n<li>An\u00e9mie, trombocytopenie, leukopenie<\/li>\n<li>Pr\u016fjem, nevolnost<\/li>\n<li>Bolest hlavy<\/li>\n<li>Bolesti kloub\u016f<\/li>\n<\/ul>\n<p><strong>Z\u00e1va\u017en\u00e9 \u2014 vy\u017eaduj\u00ed vy\u0161et\u0159en\u00ed nebo p\u0159eru\u0161en\u00ed l\u00e9\u010dby:<\/strong><\/p>\n<ul>\n<li><strong>Pneumonitida (interstici\u00e1ln\u00ed plicn\u00ed onemocn\u011bn\u00ed)<\/strong> \u2014 t\u0159\u00eddn\u00ed \u00fa\u010dinek inhibitor\u016f mTOR. Nov\u011b vznikl\u00fd ka\u0161el, du\u0161nost, hypoxie: vysadit, CT hrudn\u00edku, bronchoskopie, konzultace specialisty<\/li>\n<li><strong>Z\u00e1va\u017en\u00e9 komplikace hojen\u00ed ran<\/strong> \u2014 dehiscence, lymfok\u00e9la, infekce. Vysazen\u00ed v obdob\u00ed kolem operace<\/li>\n<li><strong>Z\u00e1va\u017en\u00e9 infekce<\/strong> \u2014 CMV, BK virus, Pneumocystis, oportunn\u00ed pl\u00eds\u0148ov\u00e9 infekce<\/li>\n<li><strong>Proteinurie<\/strong> (zejm\u00e9na v re\u017eimech bez kalcineurinu) \u2014 vy\u017eaduje \u00fapravu d\u00e1vkov\u00e1n\u00ed nebo konzultaci specialisty<\/li>\n<li><strong>Nov\u011b vznikl\u00fd diabetes po transplantaci<\/strong> \u2014 metabolick\u00fd profil sirolimu p\u0159isp\u00edv\u00e1<\/li>\n<li><strong>Lymfom a ko\u017en\u00ed n\u00e1dory<\/strong> \u2014 dlouhodob\u00e9 riziko imunosuprese; ka\u017edoro\u010dn\u00ed vy\u0161et\u0159en\u00ed k\u016f\u017ee<\/li>\n<\/ul>\n<p><strong>Vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9:<\/strong> tromb\u00f3za jatern\u00ed tepny (FDA black-box; sirolimus se vyh\u00fdb\u00e1 p\u0159i transplantaci jater), dehiscence bronchi\u00e1ln\u00ed anastom\u00f3zy (FDA black-box; sirolimus se vyh\u00fdb\u00e1 p\u0159i transplantaci plic), trombotick\u00e1 mikroangiopatie.<\/p>\n<h2 class=\"wp-block-heading\">Varov\u00e1n\u00ed a opat\u0159en\u00ed<\/h2>\n<ul>\n<li><strong>Transplantace jater:<\/strong> FDA black-box \u2014 zv\u00fd\u0161en\u00e1 mortalita a tromb\u00f3za jatern\u00ed tepny. <strong>Vyvarujte se pou\u017eit\u00ed p\u0159i transplantaci jater.<\/strong><\/li>\n<li><strong>Transplantace plic:<\/strong> FDA \u010dern\u00e1 sk\u0159\u00ed\u0148ka \u2014 dehiscence bronchi\u00e1ln\u00ed anastom\u00f3zy. <strong>Vyvarujte se pou\u017eit\u00ed u pacient\u016f po transplantaci plic v \u010dasn\u00e9m poopera\u010dn\u00edm obdob\u00ed.<\/strong><\/li>\n<li><strong>T\u011bhotenstv\u00ed:<\/strong> kontraindikov\u00e1no \u2014 teratogenn\u00ed \u00fa\u010dinek v pokusech na zv\u00ed\u0159atech. Nutn\u00e1 \u00fa\u010dinn\u00e1 antikoncepce po celou dobu l\u00e9\u010dby + 12 t\u00fddn\u016f po ukon\u010den\u00ed. Ovliv\u0148uje plodnost u mu\u017e\u016f i \u017een.<\/li>\n<li><strong>Kojen\u00ed:<\/strong> kontraindikov\u00e1no.<\/li>\n<li><strong>\u017div\u00e9 vakc\u00edny:<\/strong> kontraindikov\u00e1no.<\/li>\n<li><strong>Hojen\u00ed ran:<\/strong> p\u0159eru\u0161it 2\u20134 t\u00fddny p\u0159ed pl\u00e1novan\u00fdm chirurgick\u00fdm z\u00e1krokem; obnovit a\u017e po \u00fapln\u00e9m zahojen\u00ed r\u00e1ny.<\/li>\n<li><strong>Aktivn\u00ed z\u00e1va\u017en\u00e1 infekce:<\/strong> p\u0159eru\u0161it l\u00e9\u010dbu.<\/li>\n<li><strong>T\u011b\u017ek\u00e9 po\u0161kozen\u00ed jater:<\/strong> sn\u00ed\u017een\u00ed d\u00e1vky p\u0159ibli\u017en\u011b o jednu t\u0159etinu; pod odborn\u00fdm dohledem.<\/li>\n<li><strong>Hyperlipidemie:<\/strong> vstupn\u00ed vy\u0161et\u0159en\u00ed + m\u011bs\u00ed\u010dn\u00ed kontrola lipidov\u00e9ho panelu. P\u0159i p\u0159etrv\u00e1vaj\u00edc\u00edch pot\u00ed\u017e\u00edch l\u00e9\u010dit statinem \u2014 preferov\u00e1n pravastatin nebo fluvastatin (nejni\u017e\u0161\u00ed interakce s CYP3A4).<\/li>\n<li><strong>Monitorov\u00e1n\u00ed ko\u017en\u00edch n\u00e1dor\u016f:<\/strong> ro\u010dn\u00ed celot\u011blov\u00e9 dermatologick\u00e9 vy\u0161et\u0159en\u00ed. D\u016fsledn\u00e9 denn\u00ed pou\u017e\u00edv\u00e1n\u00ed SPF 50+.<\/li>\n<li><strong>Transplantace srdce:<\/strong> riziko mTOR inhibitor-pneumonitidy \u2014 vstupn\u00ed vy\u0161et\u0159en\u00ed plicn\u00edch funkc\u00ed + zobrazovac\u00ed vy\u0161et\u0159en\u00ed hrudn\u00edku p\u0159i p\u0159\u00edznac\u00edch.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<p>Sirolimus je substr\u00e1t CYP3A4 a P-gp \u2014 mnoho klinicky v\u00fdznamn\u00fdch interakc\u00ed.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;\">Kombinujte s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">\u00da\u010dinek<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Co d\u011blat<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Siln\u00e9 inhibitory CYP3A4 (ketokonazol, itrakonazol, vorikonazol, ritonavir, klarithromycin, grapefruitov\u00e1 \u0161\u0165\u00e1va)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hladiny sirolimu v\u00fdrazn\u011b stoupaj\u00ed \u2014 toxicita<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se kombinaci. Pokud je to nevyhnuteln\u00e9, sni\u017ete d\u00e1vku sirolimu o 50\u201375 % s intenzivn\u00edm monitorov\u00e1n\u00edm hladin.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Siln\u00e9 induktory CYP3A4 (rifampicin, karbamazepin, fenytoin, fenobarbital, t\u0159ezalka te\u010dkovan\u00e1)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hladiny sirolimu prudce klesaj\u00ed \u2014 riziko odm\u00edtnut\u00ed<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se kombinaci. Pokud je to nevyhnuteln\u00e9, zvy\u0161te d\u00e1vku sirolimu s intenzivn\u00edm monitorov\u00e1n\u00edm.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cyklosporin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cyklosporin zvy\u0161uje AUC sirolimu \u2014 standardn\u00ed kombinace, ale z\u00e1vis\u00ed na na\u010dasov\u00e1n\u00ed<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">U\u017e\u00edvejte sirolimus 4 hodiny po cyklosporinu. Standardn\u00ed transplanta\u010dn\u00ed re\u017eim s minimalizac\u00ed kalcineurinov\u00fdch inhibitor\u016f.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tacrolimus<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kombinovan\u00e1 nefrotoxicita<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Pouze odborn\u00e1 kombinace s intenzivn\u00edm monitorov\u00e1n\u00edm.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">ACE inhibitory<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Riziko angioed\u00e9mu (aditivn\u00ed \u00fa\u010dinek s inhibic\u00ed mTOR)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Opatrnost \u2014 v p\u0159\u00edpad\u011b angioed\u00e9mu p\u0159ejd\u011bte na ARB.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Statiny (simvastatin, lovastatin)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Zv\u00fd\u0161en\u00e9 hladiny statin\u016f \u2014 riziko myopatie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">P\u0159ejd\u011bte na pravastatin, fluvastatin nebo rosuvastatin (ni\u017e\u0161\u00ed z\u00e1vislost na CYP3A4).<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u017div\u00e9 vakc\u00edny<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Riziko diseminovan\u00e9 infekce vakcin\u00e1ln\u00edm kmenem<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kontraindikov\u00e1no.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Grapefruitov\u00e1 \u0161\u0165\u00e1va<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Inhibice CYP3A4 \u2014 hladiny sirolimu stoupaj\u00ed nep\u0159edv\u00eddateln\u011b<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vyhn\u011bte se po celou dobu l\u00e9\u010dby.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Pokyny k uchov\u00e1v\u00e1n\u00ed<\/h2>\n<ul>\n<li>Skladujte p\u0159i <strong>2\u20138\u00b0C<\/strong> (v chladni\u010dce). N\u011bkter\u00e9 formulace jsou stabiln\u00ed p\u0159i pokojov\u00e9 teplot\u011b po omezenou dobu \u2014 zkontrolujte \u00fadaj na obalu.<\/li>\n<li>Chra\u0148te p\u0159ed sv\u011btlem. Uchov\u00e1vejte v p\u016fvodn\u00edm blistru.<\/li>\n<li>Uchov\u00e1vejte mimo dosah d\u011bt\u00ed a dom\u00e1c\u00edch zv\u00ed\u0159at.<\/li>\n<li>Nepou\u017eit\u00e9 tablety vra\u0165te do l\u00e9k\u00e1rny k likvidaci.<\/li>\n<\/ul>\n<p><!-- medsbase-why-order --><\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Ka\u017ed\u00e1 \u0161ar\u017ee je dod\u00e1v\u00e1na od <strong>v\u00fdrobce certifikovan\u00e9ho WHO-GMP<\/strong>. Objedn\u00e1vky jsou expedov\u00e1ny v nen\u00e1padn\u00fdch obalech bez loga od na\u0161ich partnersk\u00fdch sklad\u016f a jsou pokryty na\u0161\u00ed <a href=\"\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>: pokud z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, za\u0161leme zdarma n\u00e1hradn\u00ed z\u00e1silku, bez dotaz\u016f.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed l\u00e9ky<\/h3>\n<p>Dal\u0161\u00ed l\u00e9ky skladem vedle tohoto produktu:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/rapacan\/\">Rapacan (sirolimus 1 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/cellcept\/\">Cellcept (mykofenol\u00e1t mofetil 500 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/imutrex\/\">Imutrex (methotrex\u00e1t 2,5\/7,5\/10 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/folitrax\/\">Folitrax (methotrex\u00e1t 2,5\/7,5\/10 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/endoxan\/\">Endoxan (cyklofosfamid 50 mg)<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Pro\u010d je Siromus za\u0159azen mezi protin\u00e1dorov\u00e9 l\u00e9ky?<\/h3>\n<p>Sirolimus je prim\u00e1rn\u011b imunosupresivum pro transplantace. mTOR dr\u00e1ha je zapojena do mnoha typ\u016f rakoviny a strukturn\u011b p\u0159\u00edbuzn\u00fd everolimus m\u00e1 schv\u00e1len\u00ed FDA pro n\u011bkolik onkologick\u00fdch indikac\u00ed, ale sirolimus s\u00e1m o sob\u011b nen\u00ed standardn\u00edm protin\u00e1dorov\u00fdm l\u00e9kem. Sou\u010dasn\u00e9 za\u0159azen\u00ed do kategorie se zd\u00e1 b\u00fdt historick\u00fdm taxonomick\u00fdm probl\u00e9mem.<\/p>\n<h3 class=\"wp-block-heading\">Siromus versus takrolimus \u2014 kter\u00fd je lep\u0161\u00ed?<\/h3>\n<p>Maj\u00ed r\u016fzn\u00e9 mechanismy \u00fa\u010dinku (mTOR vs kalcineurin), r\u016fzn\u00e9 profily vedlej\u0161\u00edch \u00fa\u010dink\u016f a r\u016fzn\u00e9 role. Tacrolimus je standardn\u00ed z\u00e1kladn\u00ed l\u00e9k pro \u010dasnou indukci a udr\u017eovac\u00ed l\u00e9\u010dbu po transplantaci. Sirolimus se obvykle zav\u00e1d\u00ed 2\u20134 m\u011bs\u00edce po transplantaci, \u010dasto nahrazuje nebo sni\u017euje d\u00e1vku tacrolimu, zejm\u00e9na u pacient\u016f s nefrotoxicitou zp\u016fsobenou inhibitorem kalcineurinu. Nejsou zam\u011bniteln\u00e9.<\/p>\n<h3 class=\"wp-block-heading\">Siromus versus everolimus?<\/h3>\n<p>Everolimus je analog sirolimu s hydroxyethylovou modifikac\u00ed, kter\u00e1 zaji\u0161\u0165uje krat\u0161\u00ed polo\u010das (28 vs 60 hodin), co\u017e umo\u017e\u0148uje d\u00e1vkov\u00e1n\u00ed dvakr\u00e1t denn\u011b a rychlej\u0161\u00ed \u00fapravu d\u00e1vky. Everolimus m\u00e1 v\u00edce schv\u00e1len\u00fdch indikac\u00ed (HR+ HER2- karcinom prsu s exemestanem, pokro\u010dil\u00fd ren\u00e1ln\u00ed karcinom, neuroendokrinn\u00ed n\u00e1dory, SEGA, TSC-AML, l\u00e9kov\u011b eluuj\u00edc\u00ed stenty). Sirolimus je mate\u0159sk\u00e1 slou\u010denina a st\u00e1le se \u0161iroce pou\u017e\u00edv\u00e1 v udr\u017eovac\u00ed l\u00e9\u010db\u011b po transplantaci a u LAM.<\/p>\n<h3 class=\"wp-block-heading\">Zv\u00fd\u0161\u00ed Siromus m\u00e9 riziko rakoviny?<\/h3>\n<p>Dlouhodob\u00e1 imunosuprese jak\u00fdmkoli p\u0159\u00edpravkem (sirolimus, tacrolimus, cyklosporin, mykofenol\u00e1t) zvy\u0161uje celo\u017eivotn\u00ed riziko ko\u017en\u00edch n\u00e1dor\u016f, posttransplanta\u010dn\u00edho lymfoproliferativn\u00edho onemocn\u011bn\u00ed a n\u011bkolika dal\u0161\u00edch malignit. T\u0159\u00edda inhibitor\u016f mTOR m\u016f\u017ee m\u00edt <em>ni\u017e\u0161\u00edm<\/em> ni\u017e\u0161\u00ed riziko ko\u017en\u00edch n\u00e1dor\u016f ne\u017e inhibitory kalcineurinu podle \u00fadaj\u016f z transplanta\u010dn\u00edch kohort \u2014 n\u011bkter\u00e1 centra p\u0159ev\u00e1d\u011bj\u00ed pacienty s mnoho\u010detn\u00fdmi ko\u017en\u00edmi n\u00e1dory na sirolimus. Ro\u010dn\u00ed vy\u0161et\u0159en\u00ed cel\u00e9ho t\u011bla + denn\u00ed pou\u017e\u00edv\u00e1n\u00ed SPF 50+ je standard bez ohledu na re\u017eim.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d pot\u0159ebuji krevn\u00ed test na sirolimus?<\/h3>\n<p>Sirolimus m\u00e1 \u00fazk\u00e9 terapeutick\u00e9 okno. Pod c\u00edlovou hladinou riskujete odm\u00edtnut\u00ed transplant\u00e1tu; nad c\u00edlovou hladinou riskujete pneumonitidu, t\u011b\u017ekou hyperlipidemii, infekci a dal\u0161\u00ed toxicitu. Standardn\u00edm monitorovac\u00edm vzorkem je 24hodinov\u00e1 p\u0159edd\u00e1vkov\u00e1 hladina v pln\u00e9 krvi. C\u00edle se li\u0161\u00ed podle indikace a re\u017eimu \u2014 v\u00e1\u0161 transplanta\u010dn\u00ed t\u00fdm stanov\u00ed v\u00e1\u0161 c\u00edl.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017eu podstoupit operaci p\u0159i u\u017e\u00edv\u00e1n\u00ed Siromusu?<\/h3>\n<p>Sirolimus naru\u0161uje hojen\u00ed ran inhibic\u00ed proliferace fibroblast\u016f a endoteli\u00e1ln\u00edch bun\u011bk prost\u0159ednictv\u00edm mTOR. P\u0159i pl\u00e1novan\u00fdch operac\u00edch se sirolimus obvykle vysazuje 2\u20134 t\u00fddny p\u0159ed v\u00fdkonem a obnovuje po dobr\u00e9m zahojen\u00ed r\u00e1ny (obvykle 2\u20134 t\u00fddny po operaci). P\u0159i nouzov\u00fdch operac\u00edch se sirolimus okam\u017eit\u011b vysad\u00ed a pod veden\u00edm transplanta\u010dn\u00edho t\u00fdmu se nahrad\u00ed re\u017eimem zalo\u017een\u00fdm na inhibitoru kalcineurinu.<\/p>\n<h3 class=\"wp-block-heading\">Pro\u010d mus\u00edm Siromus u\u017e\u00edvat pravideln\u011b, a\u0165 u\u017e s j\u00eddlem nebo bez?<\/h3>\n<p>Vysokotu\u010dn\u00e1 strava zvy\u0161uje AUC sirolimu asi o 35 % a vrcholovou koncentraci asi o 65 %. Pokud st\u0159\u00edd\u00e1te d\u00e1vkov\u00e1n\u00ed nala\u010dno a po j\u00eddle, va\u0161e hladiny p\u0159ed d\u00e1vkou se stanou nep\u0159edv\u00eddateln\u00e9. Zvolte si rutinu (v\u011bt\u0161ina lid\u00ed preferuje konzistentn\u00ed d\u00e1vkov\u00e1n\u00ed nala\u010dno, proto\u017ee je snaz\u0161\u00ed ji dodr\u017eovat) a dr\u017ete se j\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Jsou Rapacan a Siromus stejn\u00e9 jako Rapamune?<\/h3>\n<p>Ano \u2014 Rapacan, Siromus a Rapamune jsou v\u0161echny sirolimus 1 mg. Rapamune je p\u016fvodn\u00ed zna\u010dka od Wyeth\/Pfizer. Rapacan a Siromus jsou bioekvivalentn\u00ed generick\u00e9 verze od r\u016fzn\u00fdch v\u00fdrobc\u016f.<\/p>\n<h3 class=\"wp-block-heading\">Co je LAM?<\/h3>\n<p>Lymfangioleiomyomat\u00f3za je vz\u00e1cn\u00e9 progresivn\u00ed cystick\u00e9 plicn\u00ed onemocn\u011bn\u00ed, kter\u00e9 postihuje t\u00e9m\u011b\u0159 v\u00fdhradn\u011b \u017eeny a je \u010dasto spojeno s tuber\u00f3zn\u00ed skler\u00f3zou. Inhibice mTOR pomoc\u00ed sirolimu stabilizuje plicn\u00ed funkci (FEV1) u LAM \u2014 studie MILES vedla ke schv\u00e1len\u00ed FDA v roce 2015. LAM je diagnostikov\u00e1no a l\u00e9\u010deno ve specializovan\u00fdch centrech.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017eu p\u00edt alkohol p\u0159i u\u017e\u00edv\u00e1n\u00ed Siromusu?<\/h3>\n<p>Nejsou zn\u00e1my specifick\u00e9 interakce s alkoholem. M\u00edrn\u00e1 konzumace je obecn\u011b p\u0159ijateln\u00e1, ale alkohol zhor\u0161uje hyperlipidemii (b\u011b\u017en\u00fd vedlej\u0161\u00ed \u00fa\u010dinek sirolimu) a m\u016f\u017ee ovliv\u0148ovat jatern\u00ed metabolismus. Pokud m\u00e1te transplantovan\u00e1 j\u00e1tra nebo jin\u00e9 jatern\u00ed onemocn\u011bn\u00ed, je alkohol kontraindikov\u00e1n.<\/p>\n<p style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:24px 0;border-radius:4px;font-size:13px;\"><strong>Zdravotn\u00ed upozorn\u011bn\u00ed:<\/strong> Tato produktov\u00e1 str\u00e1nka slou\u017e\u00ed pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou pomoc. Imunosupresiva mohou zp\u016fsobit \u017eivot ohro\u017euj\u00edc\u00ed infekce, malignity a vrozen\u00e9 vady. Pou\u017e\u00edvejte pouze pod odborn\u00fdm dohledem s vhodn\u00fdm monitorov\u00e1n\u00edm.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Imunosupresivn\u00ed l\u00e9k<br \/>\n\u2705 Zabr\u00e1n\u00ed odm\u00edtnut\u00ed org\u00e1nu<br \/>\n\u2705 L\u00e9\u010dba lymfangioleiomyomat\u00f3zy<br \/>\n\u2705 Sni\u017euje po\u0161kozen\u00ed ledvin<br \/>\n\u2705 Kontroluje revmatoidn\u00ed artritidu<\/p>","protected":false},"featured_media":53495,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[],"class_list":{"0":"post-53494","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/53494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=53494"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/53495"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=53494"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=53494"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=53494"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=53494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}